I

Immuneering Corp
D

IMRX

2.54000
USD
-0.26
(-9.12%)
مغلق
حجم التداول
78,626
الربح لكل سهم
-2
العائد الربحي
-
P/E
-1
حجم السوق
91,403,683
أصول ذات صلة
BIIB
BIIB
0.480
(0.38%)
127.050 USD
C
CRSP
-0.190
(-0.43%)
44.240 USD
E
EDIT
-0.11500
(-4.90%)
2.23000 USD
G
GLPG
-0.790
(-2.80%)
27.440 USD
N
NTLA
-0.41000
(-4.27%)
9.19000 USD
R
RARE
-0.210
(-0.56%)
37.140 USD
REGN
REGN
-3.73
(-0.73%)
509.70 USD
V
VCEL
0.260
(0.62%)
42.040 USD
VRTX
VRTX
-7.64
(-1.70%)
440.97 USD
المزيد
الأخبار المقالات

العنوان: Immuneering Corp

القطاع: Healthcare
الصناعة: Biotechnology
Immuneering Corp is a biopharmaceutical company. It is focused on improving patient outcomes across a spectrum of debilitating oncologic and neurologic diseases by applying deep knowledge of translational bioinformatics to every stage of the drug development process. The company's proprietary computational Disease Cancelling Technology platform enables Immuneering's drug discovery programs. The company also provides unparalleled computational biology capabilities to pharmaceutical and biotechnology companies.